Literature DB >> 16686366

Transporters and drug discovery: why, when, and how.

Richard B Kim1.   

Abstract

Drug transporters are now increasingly recognized as important determinants of variable drug disposition and response. In addition, transporter associated problems appear to be occurring with greater frequency during the drug discovery and development process. What has not been clear is whether drug transporter related issues are a truly new problem, or whether such issues had existed all along, but were previously unrecognized or ignored. In this review, a brief overview of key drug transporters will be outlined. In addition, a commentary on specific issues of relevance to pharmaceutical sciences in terms of the role and relevance of drug transporters to the drug discovery and development process is provided.

Mesh:

Substances:

Year:  2006        PMID: 16686366     DOI: 10.1021/mp050084o

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  13 in total

Review 1.  Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Authors:  David G Bailey
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

2.  Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1.

Authors:  Tao Yang; Brian F McBride; Brenda F Leake; Richard B Kim; Dan M Roden
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 3.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

4.  The impact of window functions on NMR-based paramagnetic relaxation enhancement measurements in membrane proteins.

Authors:  Wade D Van Horn; Andrew J Beel; Congbao Kang; Charles R Sanders
Journal:  Biochim Biophys Acta       Date:  2009-09-12

5.  A modified serial blood sampling technique and utility of dried-blood spot technique in estimation of blood concentration: application in mouse pharmacokinetics.

Authors:  Vishwanath Kurawattimath; Krishna Pocha; T Thanga Mariappan; Ravi Kumar Trivedi; Sandhya Mandlekar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-09-25       Impact factor: 2.441

Review 6.  Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.

Authors:  Anand Balakrishnan; James E Polli
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

Review 7.  Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.

Authors:  John J Lima
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.

Authors:  Y Shu; C Brown; R A Castro; R J Shi; E T Lin; R P Owen; S A Sheardown; L Yue; E G Burchard; C M Brett; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2007-07-04       Impact factor: 6.875

9.  Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir.

Authors:  O Janneh; R C Hartkoorn; E Jones; A Owen; S A Ward; R Davey; D J Back; S H Khoo
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

10.  Molecular docking study of lignanamides from Cannabis sativa against P-glycoprotein.

Authors:  Farnoosh Kazemi; Isaac Karimi; Namdar Yousofvand
Journal:  In Silico Pharmacol       Date:  2021-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.